Prefrontal transcranial magnetic stimulation for depression in US military veterans – A naturalistic cohort study in the veterans health administration von Madore, Michelle R., Kozel, F. Andrew, Williams, Leanne M., Green, L. Chauncey, George, Mark S., Holtzheimer, Paul E., Yesavage, Jerome A., Philip, Noah S.

Volltext

71 Treatment with TMS Improves Aspects of Attention in Depression: A Pilot Study von Walker, Nicole C, Ramirez, Nathan, Chin, Laurie, Rehman, Sonia S, Gee, Stephanie C, Hodges, Kathleen, Williams, Leanne M, Hickson, Robert, Chauncey Green, L., Patton, Talaya, Aldasouqi, Hanaa, Philip, Noah S, Andrew Kozel, F., Yesavage, Jerome A, Madore, Michelle R

Volltext

Prefrontal Transcranial Magnetic Stimulation for Depression in US Military Veterans – A Naturalistic Study in the Veterans Health Administration von Kozel, F. Andrew, Madore, Michelle, Williams, Leanne, Green, L. Chauncey, George, Mark, Holtzheimer, Paul, Yesavage, Jerome, Philip, Noah

Volltext

Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma von Graf, S.A., Stevenson, P.A., Holmberg, L.A., Till, B.G., Press, O.W., Chauncey, T.R., Smith, S.D., Philip, M., Orozco, J.J., Shustov, A.R., Green, D.J., Libby, E.N., Bensinger, W.I., Pagel, J.M., Maloney, D.G., Zhou, Y., Cassaday, R.D., Gopal, A.K.

Volltext

A randomized study of melphalan 200 mg/m(2) vs 280 mg/m(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCT von Bensinger, W I, Becker, P S, Gooley, T A, Chauncey, T R, Maloney, D G, Gopal, A K, Green, D J, Press, O W, Lill, M, Ifthikharuddin, J J, Vescio, R, Holmberg, L A, Phillips, G L

Volltext

A randomized study of melphalan 200 mg/m2 vs 280 mg/m2 as a preparative regimen for patients with multiple myeloma undergoing auto-SCT von Bensinger, W I, Becker, P S, Gooley, T A, Chauncey, T R, Maloney, D G, Gopal, A K, Green, D J, Press, O W, Lill, M, Ifthikharuddin, J J, Vescio, R, Holmberg, L A, Phillips, G L

Volltext

A randomized study of melphalan 200 mg/m super(2) vs 280 mg/m super(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCT von Bensinger, W I, Becker, P S, Gooley, T A, Chauncey, T R, Maloney, D G, Gopal, A K, Green, D J, Press, O W, Lill, M, Ifthikharuddin, J J, Vescio, R, Holmberg, L A, Phillips, G L

Volltext

Randomized Comparison of Melphalan 200 Mg/m2 v. 280 Mg/m2 As a Preparative Regimen for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation von Bensinger, William I., Becker, Pamela S, Gooley, Ted A., Chauncey, Thomas, Maloney, David G., Vescio, Robert, Gopal, Ajay K., Green, Damian J., Press, Oliver W., Lill, Michael, Holmberg, Leona, Ifthikharuddin, Jainulabdeen J, Phillips, Gordon L.

Volltext

Specific Features Identify Patients with Relapsed or Refractory Mantle Cell Lymphoma Benefitting from Autologous Hematopoietic Cell Transplantation von Cassaday, Ryan D, Guthrie, Katherine A, Budde, Elizabeth L, Thompson, Leslie, Till, Brian G, Press, Oliver W, Chauncey, Thomas R, Pagel, John M, Petersdorf, Stephen H, Palanca-Wessels, Maria Corinna, Philip, Mary, Bensinger, William I, Holmberg, Leona A, Shustov, Andrei, Green, Damian J, Libby, Edward N, Maloney, David G, Gopal, Ajay K

Volltext